In a 2026 editorial commentary published in Cureus , citing findings from the STEP 4 and SURMOUNT 4 clinical trials, the author described how stopping GLP-1 medication may unmask counter-regulatory hunger signals including potential changes in ghrelin activity that had been suppressed while the medication was active (Quimbayo-Cifuentes, 2026)
- Oral semaglutide (only FDA approved for diabetes treatment) and injectable liraglutide, (FDA approved for obesity treatment as Saxenda,) lead to relatively modest amount of weight loss
ACE-031 works by inhibiting myostatin, a protein that limits muscle growth, thereby promoting increased muscle mass and strength
Sunflower Seeds and Chia Seeds: Plant-based options for mineral support
Documentation literature emphasizes that records create a detailed picture of what was done and what material is being represented [28]
Diabetes is a long-term health condition in which the body struggles to control blood sugar levels